baber/WOPTO huggingface dataset:
Patent DK-429586-D0 (DK)
Inventor: MALABARBA ADRIANO
IPC: C07K7/06
Filed: 1986-09-09
Abstract: The present invention relates to amide derivatives of teicoplanin compounds. Teicoplanin is an antibiotic substance active mainly against gram-positive bacteria and its derivatives, which are collectively named "teicoplanin compounds", are the components, pseudoaglycones and aglycone thereof. The compounds of the invention are obtained according to a proper amidation process and are active as antibiotics.
Patent DK-524985-D0 (DK)
Inventor: ALLAN GEORG GRAHAM
IPC: C05G3/60
Filed: 1985-11-14
Abstract: Liquid compositions provide a source of a herbicide or other biologically active substance in combination with a particular nitrogenous chemical, preferably melamine. After application, the herbicide is characterized by enhanced efficacy as compared to the efficacy observed when applied alone.
Patent DK-629789-D0 (DK)
Inventor: THEN JOHANN
IPC: C12P41/00
Filed: 1989-12-13
Abstract: L-2-amino-4-methylphosphinobutyric acid can be prepared by racemate resolution in the presence of D-amino-acid transaminase and L-amino- acid transaminase by reaction with  alpha -keto acids and amino-group donors.
Patent NO-864616-D0 (NO)
Inventor: INCE FRANCIS
IPC: C07C409/44
Filed: 1986-11-19
Abstract: There are described compounds of formula I, in which X represents a C2 to 8 alkylene chain optionally interrupted by a double bond or by S(O)<sub>n</sub>, wherein n is 0, 1 or 2;Y represents O or NH,l and m each independently represent 2, 3 or 4,R₁₀ represents phenyl substituted by one or more substituents R₂₃, which may be the same or different; or R₁₀ represents pyridyl, a saturated carbocyclic group, alkyl C 1 to 6 or hydrogen,R₁₅ represents hydrogen or together with R₂₃ forms a (CH₂)<sub>p</sub> chain, wherein p represents 0, 1 or 2;R₂₀, R₂₁, R₂₂ and R₂₃, which may be the same or different, independently represent hydrogen, alkyl C 1 to 6, NHR₂₅, SH, NO₂, halogen, CF₃, SO₂R₃₀, CH₂OH or OH, wherein R₂₅, represents hydrogen, alkyl C 1 to 6, alkanoyl C 1 to 6 or SO₂ alkyl C 1 to 6, and R₃₀ represents alkyl C 1 to 6 or NH₂,provided that when X represents an uninterrupted C4 alkylene chain, Y represents NH, m represents 2, l represents 2, R₁₀ represents phenyl, R₁₅ represents hydrogen, and R₂₁, R₂₂ and R₂₃ represent hydrogen, then R₂₀ does not represent hydrogen or 4-OH,and pharmaceutically acceptable salts and solvates thereof.There are also described processes for the preparation of the compounds of formula I and pharmaceutical compositions containing them. The compounds of the invention may be used in the treatment or prophylaxis of renal failure or cardiovascular disorders.
Patent NO-881591-D0 (NO)
Inventor: KELDANY RACHID
IPC: B29C53/60
Filed: 1988-04-13
Abstract: The tube-winding apparatus has a winding drum (1), which has a casing formed by elongated cylindrical elements (4, 5). Some of these elements, namely the circumferential rollers (5) are motor-driven, usually by means of the normal drive of the winding apparatus, in order to support the tube or band drive and the tube advancement. 
<IMAGE>
Patent NO-884336-D0 (NO)
Inventor: BOEE EINAR
IPC: F17C1/00
Filed: 1988-09-29
Abstract: A sample container (1) especially for oil/gas samples consists mainly of a spherical body formed of two half parts (2, 3) with a metal membrane (4) fixed between the flanges of the two half parts. The membrane has a configuration complementary to the configuration of each half part and is substantially hemispherical with a planar portion (8) perpendicular to the in-/outlet passages (9, 10). The flange (13) of the membrane forms the packing between the two halves of the container. The membrane may be equipped with a reinforcement plate (14) perpendicular to the in-/outlet passages. To ensure that the container is leakage proof at large pressure variations, the container is at the oil/gas side equipped with a resilient packing nose (16) and labyrinth packing (17). The in-/outlet passages are formed as annular gaps (21). The container has only metallic packings.
Patent NO-884808-D0 (NO)
Inventor: SARKOZI IMRE
IPC: H04L7/02
Filed: 1988-10-27
Abstract: A digital clock recovery system according to the prior art contains a phase sensor with a delay device. This cannot be implemented with the required accuracy in integrated circuit technology. The invention does not required any delay device for its implementation. A phase sensor (6) does not compare the phase relationship of the active edges of the pulses of a digital signal (DS) with a first auxiliary data clock (DHT1) which acts as clock recovered from the digital signal (DS), but instead, at phase sensor (6) compares the phase relationship of the active edges of the pulses of the digital signal (DS) and a second auxiliary data clock (DHT2) which has a defined phase difference relative to the first auxiliary data clock (DHT1). If the comparison does not result in a phase difference, a correction signal (K) is generated which causes a phase correction of both of the auxiliary data clocks (DHT1, DHT2) which produce the defined phase difference. Digital clock recovery devices are used in digital signal multiplexing devices and distributor multiplexors between, in particular, higher levels of a digital signal hierarchy.
Patent NO-901306-D0 (NO)
Inventor: DAELE GEORGES HENRI PAUL VAN
IPC: C07D307/78
Filed: 1990-03-21
Abstract: N-(3-hydroxy-4-piperidinyl)(dihydrobenzofuran, dihydro-2H-benzopyran or dihydrobenzodioxin)carboxamide derivatives of formula <CHEM> wherein A is -CH2-CH2-, -CH2-CH2-CH2-, -CH2-CH2-CH2-CH2-, -CH2-O-, -CH2-CH2-O- or -CH2-CH2-CH2-O-,  R<1> is hydrogen, halo, C1-6alkylsulfonyl or aminosulfonyl; R<2> is hydrogen, amino, mono or di(C1-6alkyl)amino, arylC1-6alkylamino or C1-6alkylcarbonylamino;  R<3> and R<4> are hydrogen or C1-6alkyl; L is C3-6cycloalkyl, C5-6cycloalkanone, C3-6alkenyl optionally substituted with aryl, or L is -Alk-R<5>, -Alk-X-R<6>, -Alk-Y-C(=O)-R<8> or -Alk-Y-C(=O)-NR<1><0>R<1><1>; the N-oxides, the pharmaceutically acceptable acid addition salts and possible stereochemically isomeric forms thereof. Said compounds have gastrointestinal stimulating activity. Pharmaceutical compositions containing such compounds as an active ingredient; methods of preparing said compounds and pharmaceutical compositions.
Patent NO-914575-D0 (NO)
Inventor: LESPADE JEAN-PIERRE
IPC: D06M23/00
Filed: 1991-11-22
Abstract: Process for obtaining a composite material with controlled electromagnetic properties and with fibre reinforcement, consists essentially in:   a) - impregnating (10) each fibre with a solution containing pulverulent fillers with electromagnetic properties, a solvent and a first binder soluble in the solvent,   b) - evaporating the solvent from the filled fibres, c) - weaving (40) the filled fibres obtained in b) to form the reinforcement, and d) - stiffening (50) the reinforcement obtained in c) with a second binder.   <IMAGE>
Patent NO-921783-D0 (NO)
Inventor: TAKAHASHI SHUJI
IPC: C07D495/06
Filed: 1992-05-06
Abstract: The present invention relates to a novel antibacterial compound of formula (I) from the genus Alteromonas and which shares structural similarity with the pseudomonic acids. <CHEM> i
Patent NO-934680-D0 (NO)
Inventor: STEPP MICHAEL
IPC: C08L83/08
Filed: 1993-12-17
Abstract: PCT No. PCT/EP92/01385 Sec. 371 Date Dec. 17, 1993 Sec. 102(e) Date Dec. 17, 1993 PCT Filed Jun. 19, 1992 PCT Pub. No. WO93/00405 PCT Pub. Date Jan. 7, 1993.Disclosed are organopolysiloxane preparations containing: A) units of the formula (I): (R1O)aSiHR22-aO1/2, in which R1 and R2, which may be the same or different, are each, independently of each other, an optionally substituted monovalent hydrocarbon group and a is 1 or 2, B) siloxane units which can be cross-linked by irradiating and, optionally, C) siloxane units acting as photo-initiators. These preparations are useful for the production of coatings.
Patent NO-942398-D0 (NO)
IPC: B23D47/00
Filed: 1994-06-23
Abstract: PCT No. PCT/DE93/00014 Sec. 371 Date Jul. 8, 1994 Sec. 102(e) Date Jul. 8, 1994 PCT Filed Jan. 13, 1993 PCT Pub. No. WO93/13919 PCT Pub. Date Jul. 22, 1993The invention relates to an anti-splintering device for sawing machines having a saw blade which can be operationally connected to a saw blade, can be laid on workpieces and can be arranged laterally in relation to the saw blade and in the region of the saw blade teeth emerging from the workpiece. The anti-splintering device is in pressure contact with the emerging saw blade teeth.
Patent NO-951846-D0 (NO)
Inventor: CHEUNG NELSON
IPC: F16C35/06
Filed: 1995-05-10
Abstract: A rotary apparatus (10), such as a pneumatic motor, comprises an end plate (20) having a race cavity (22), a main rotor (30) with a stub shaft (32) extending from one end, and a bearing (40), which includes an outer race (42) seated in the race cavity (22) and an inner race (44) having a central bore (50). The stub shaft (32) is fitted into the central bore (50) with a frictional fit. The threaded shank (62) of a screw (60) is threaded into a threaded socket (80) in the stub shaft (32) and is used to draw the stub shaft (32) into the central bore (50) with a washer (70) bearing against a head (64) of the screw, and against the inner race (44), whereby a controlled gap (g) can be provided between an outer surface (36) of the main rotor (30) and an inner surface (26) of the end plate (20). <IMAGE>
Patent NO-964968-D0 (NO)
Inventor: SAMUELSSON HANS OLOV
IPC: D21C9/10
Filed: 1996-11-22
Abstract: PCT No. PCT/SE95/00433 Sec. 371 Date Dec. 30, 1996 Sec. 102(e) Date Dec. 30, 1996 PCT Filed Apr. 21, 1995 PCT Pub. No. WO95/32332 PCT Pub. Date Nov. 30, 1995A method that solves the problem of suppressing disturbing effects of transition and alkaline earth metal compounds during bleaching of chemically digested lignocellulosic pulp in a sequence with oxygen bleaching prior to oxidative stages with introduction of for instance ozone, superoxides, hydrogen peroxide and peroxy acids. The conditions during the oxygen bleaching are chosen so that the properties of these metal compounds are changed and the compounds removed from the pulp during the oxygen bleaching under such conditions that the attack on the cellulose is small and the fluctuations of the pulp quality due to fluctuating amounts of these metal compounds decrease markedly.
Patent NO-965150-D0 (NO)
Inventor: BORZATTA VALERIO
IPC: C07D/
Filed: 1996-12-03
Abstract: Compounds of the formula (I)in which the polydispersity {overscore (M)}w/{overscore (M)}n is 1; n is 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14 or 15; the radicals R1 are for example hydrogen or C1-C8alkyl; R2 is for example C2-C12alkylene; the radicals A are independently of one another -OR3, -N(R4)(R5) or a group of theR3, R4 and R5, which are identical or different, are for example hydrogen or C1-C18alkyl, or -N(R4)(R5) is additionally a group of the formulawith Y being -O-, -CH2-, -CH2CH2- or >N-CH3; X is -O- or >N-R6; R6 is for example hydrogen or C1-C18alkyl; R is preferably a group of the formulaand the radicals B have independently of one another one of the definitions given for A; with the proviso that in the individual recurrent units of the formula (I), each of the radicals B, R, R1 and R2 has the same or a different meaning, are useful as light stabilizers, heat stabilizers and oxidation stabilizers for organic materials, in particular synthetic polymers.
Patent NO-971111-D0 (NO)
Inventor: BERGERON MICHEL G
IPC: C12Q1/689
Filed: 1997-03-11
Abstract: The present invention relates to DNA-based methods for universal bacterial detection, for specific detection of the pneumoniae, Pseudomonas aeruginosa, Proteus mirabilis, Streptococcus pneumoniae, Staphylococcus aureus, Staphylococcus epiderminis, Enterococcus faecalis, Staphylococcus saprophyticus, Streptococcus pyogenes, Haemophilus influenzae and Moraxella catarrhalis as well as for specific detection of commonly encountered and clinically relevant bacterial antibiotic resistance genes directly from clinical specimens or, alternatively, from a bacterial colony. The above bacterial species can account for as much as 80% of bacterial pathogens isolated in routine microbiology laboratories. The core of this invention consists primarily of the DNA sequences from all species-specific genomic DNA fragments selected by hybridization from genomic libraries or, alternatively, selected from data banks as well as any oligonucleotide sequences derived from these sequences which can be used as probes or amplification primers for PCR or any other nucleic acid amplification methods. This invention also includes DNA sequences from the selected clinically relevant antibiotic resistance genes.
Patent NO-995094-D0 (NO)
Inventor: WANG YAN
IPC: C07D213/64
Filed: 1999-10-19
Abstract: This invention is related to carbocyclic and heterocyclic substituted semicarbazones and thiosemicarbazones represented by Formula I:or a pharmaceutically acceptable salt or prodrug thereof, wherein:Y is oxygen or sulfur; R1, R21, R22 and R23 are independently hydrogen, alkyl, cycloalkyl, alkenyl, alkynyl, haloalkyl, aryl, aminoalkyl, hydroxyalkyl, alkoxyalkyl or carboxyalkyl; or R22 and R23, together with the N, form a heterocycle; A1 and A2 are independently aryl, heteroaryl, saturated or partially unsaturated carbocycle or saturated or partially unsaturated heterocycle, any of which is optionally substituted; X is one or O, S, NR24, CR25R26, C(O), NR24C(O), C(O)NR24, SO, SO2 or a covalent bond; where R24, R25 and R26 are independently hydrogen, alkyl, cycloalkyl, alkenyl, alkynyl, haloalkyl, aryl, aminoalkyl, hydroxyalkyl, alkoxyalkyl or carboxyalkyl. The invention also is directed to the use of carbocycle and heterocycle substituted semicarbazones and thiosemicarbazones for the treatment of neuronal damage following global and focal ischemia, for the treatment or prevention of neurodegenerative conditions such as amyotrophic lateral sclerosis (ALS), for the treatment and prevention of otoneurotoxicity and eye diseases involving glutamate toxicity and for the treatment, prevention or amelioration of pain, as anticonvulsants, and as antimanic depressants, as local anesthetics, as antiarrhythmics and for the treatment or prevention of diabetic neuropathy and urinary incontinence.
Patent GB-0030304-D0 (GB)
Title: Compounds
IPC: C07D417/14
Filed: 2000-12-13
Abstract: A process for the preparation of compounds of formula (I) <CHEM> in which R2, X, Y, Cy, L and Lp(D)n have the meanings given in the specification, which are inhibitors of the serine protease, Factor Xa and are useful in the treatment of cardiovascular disorders, and intermediates useful in the preparation of the compounds.
Patent GB-0300599-D0 (GB)
Title: Magnetic threads
IPC: B42D15/00
Filed: 2003-01-10
Abstract: The current invention relates to a security element for security substrates, such as those used for banknotes and the like, having enhanced public recognition, anti-counterfeit and detection properties. A security element comprising an elongate strip of a light transmitting polymeric substrate, said substrate being provided with a magnetic feature and a metallic design, the metallic design being provided by a combination of metal and non-metallic regions and comprising indicia, characters, patterns, designs, or geometrical shapes or a combination of the aforesaid design comprising at least one repeating pattern or which one or more of the frequency, the instantaneous amplitude and/or the maximum amplitude of the pattern varies along the length of the element, said pattern being positioned relative to the magnetic feature such that it does not overlap therewith.
Patent GB-0501331-D0 (GB)
Title: Bag with anti-tipping foot adapted to serve as a paper support
IPC: A45C3/02
Filed: 2005-01-21
Abstract: The bag (10) has an anti-tipping foot (30) provided at one side of the bag via a pivot bolt located within an area of the bag overlapping the anti-tipping foot, where the bag with the anti-tipping foot serves as a paper support. The anti-tipping foot includes an end that is partially provided with a rough top surface. A slide is provided at a free end with a flange (E), and a slide longitudinally movably located in a case.
Patent GB-0525587-D0 (GB)
Title: A dispensing device
IPC: B67D99/00
Filed: 2005-12-16
Abstract: A dispensing device usable for instance for dispensing liquids from a container is operated by a resilient button which causes pegs to slide over respective cam surfaces between open and closed conditions.
Patent GB-0621013-D0 (GB)
Title: A pile and method of constructing the same
Filed: 2006-10-20
Abstract: A method of forming a pile foundation comprises: forming a bore (10) in the ground to a required depth; disposing a cylinder (14) in the bore; filling the bore with uncast concrete (24) so that, on hardening, a cast concrete pile is formed in the bore, the pile having a longitudinal cavity (16) permitting access to the pile along at least a portion of its length. The longitudinal cavity is sufficiently wide to allow access to the longitudinal cavity so that cast concrete can be tested at a time after construction.
Patent GB-0913596-D0 (GB)
Title: Forceps
Filed: 2009-08-04
Abstract: A pair of forceps (1) comprises a pair of arms (3,5) connected to one another at their proximal ends (6,7). The distal ends (9,10) of he arms may be manipulated towards one another for gripping syringes and needles in use. The distal ends (9,10) of each of the arms define respective opposed gripping areas (11,13). Each gripping area (11,13) is provided with two different gripping profiles. The first gripping profiles (39,43) are adapted for gripping syringes, while a second gripping profile (41,45) at the distal tip of each arm is configured to snugly fit around a needle to enable gripping of needles. Each arm has an operating portion intended to be gripped manually by a user to operate the forceps in use. A guard (23,25) extends outwardly from the outer surface of each arm (3,5) to prevent a user's finger sliding down from the operating regions (21,22) towards the distal ends (9,10) of the arm.
Patent GB-8308849-D0 (GB)
Title: Anthelmintic preparations
IPC: A61K33/04
Filed: 1983-03-30
Abstract: A veterinary preparation comprising an effective amount of an anthelmintic agent, preferably fenbendazole, and a non-toxic amount of selenium salt, preferably sodium selenate, effective to prevent selenium deficiency in an animal. Preferably, a non-toxic amount of a cobalt salt effective to prevent cobalt deficiency in an animal is also included. By combining selenium with an anthelmintic agent, the safety margin for selenium is greatly increased.
Patent GB-8311725-D0 (GB)
Title: Device for joining ends of extruded profiles
IPC: B29C65/02
Filed: 1983-04-29
Abstract: The adjacent, mitred ends of extruded sealing profiles, which are combined to a form a frame and are made of rubber or rubber-like plastics materials, are usually adhesively joined together in a small mould. According to the invention, the resistance to tearing of the adhesive connection thereby produced is substantially increased when an additional substance, such as rubber or a rubber-like plastics material, is simultaneously injected into the internal angular region of the corner connection. <IMAGE>
Patent GB-8320005-D0 (GB)
Title: Benzothiazoline derivatives
IPC: A61K31/425
Filed: 1983-07-25
Abstract: A compound of the formula:  <IMAGE>  wherein R1 is lower alkyl, and R2 is hydrogen lower alkyl, carboxy(lower)alkyl, lower alkoxy(lower)alkyl, aliphatic acyl (lower)alkyl, aromatic acyl(lower)alkyl or heterocyclic acyl(lower)alkyl, and pharmaceutically acceptable salts thereof are useful for treatment of hypertension, heart disease and thrombosis.
Patent GB-8527756-D0 (GB)
Title: Aromatic polymer & process
IPC: C08G65/40
Filed: 1985-11-11
Abstract: Aromatic polyethers are produced by polycondensing monomers containing phenolic groups and aromatic halogen, at least some of the aromatic halogen - containing monomers being free of activating groups such as -CO- or -SO<sub>2</sub>-, in the presence of a copper-containing catalyst and of a basic alkali metal compound present in stoichiometric excess relative to phenolic groups and copper. The products include new polyethers, particularly containing the repeating unit Ph<sup>1</sup>-PH<sup>1</sup>-O alone or with ketone containing or sulphone-containing units, where Ph' is phenylene.
Patent GB-8718499-D0 (GB)
Title: Container
IPC: B65D19/06
Filed: 1987-08-05
Abstract: The invention discloses the provision of a container means securable to a pallet (2) to prevent the container or other goods to be carried from becoming dislodged from the pallet in transit. The invention provides a container having a base (4) and side wall means (3), the base means (4) having a plurality of articulatable lug means in the from of elongate tabs (8) depending therefrom and each foldable to engage with a slot (10) provided in the base so as to form a retaining loop which secures a portion (17) of the pallet member between the tabs (8) and the base of the container. The container may be erected from a blank, also described.
Patent GB-8725515-D0 (GB)
Title: Distribution frame
IPC: H04Q1/14
Filed: 1987-10-30
Abstract: A distribution frame for an optical fibre transmission system comprises connection fibres which pass between pairs of resilient separating straps (3) which bear against the sides of the connection fibres and hold them apart.
Patent GB-8804188-D0 (GB)
Title: Pharmaceutical compositions
IPC: C07C57/03
Filed: 1988-02-23
Abstract: PCT No. PCT/GB88/00373 Sec. 371 Date Sep. 25, 1989 Sec. 102(e) Date Sep. 25, 1989 PCT Filed May 13, 1988 PCT Pub. No. WO89/08095 PCT Pub. Date Sep. 8, 1989.A composition for the treatment of adrenoleukodystrophy comprises a mixture of erucic acid and less than 20% of C20:1, in the absence of any C24:0 and C26:0 acids (all the acids being as such or in the form of physiologically acceptable derivatives, e.g. the triglycerides). For dietary administration, the compositions are preferably mixed with a dietary supplement comprising glyeceryl trioleate.
Patent GB-8813295-D0 (GB)
Title: Contact lens cleaner
IPC: G02C13/00
Filed: 1988-06-06
Abstract: PCT No. PCT/GB88/00573 Sec. 371 Date Jan. 16, 1990 Sec. 102(e) Date Jan. 16, 1990 PCT Filed Jul. 18, 1988 PCT Pub. No. WO89/00429 PCT Pub. Date Jan. 26, 1989.A rotating agitational device, upon which is mounted a case (14) containing at least one lens and lens cleaning fluid, is electrically driven in a figure eight motion. This causes the contact or each lens to move about rapidly and clean itself automatically in a time of up to 60 seconds. The frequency of the agitations is between 10 and 100 Hz and is preferably between 35 and 45 Hz.
Patent GB-8904855-D0 (GB)
Title: Pharmaceutical treatment
IPC: A61K31/675
Filed: 1989-03-03
Abstract: Pharmaceutical use of a compound of formula (A): <CHEM> or a pro-drug, or a pharmaceutically acceptable salt, phosphate ester and/or acyl derivative of either of the foregoing; in the treatment of hepatitis B virus infections.
Patent GB-8908480-D0 (GB)
Title: Suspension thrust bearings
IPC: B60G15/06
Filed: 1989-04-14
Abstract: A suspension thrust bearing 9 comprises an upper ring 12, a lower ring 13, balls 14, a housing 25 for the balls, and a sleeve 15 for fixing the two rings together axially, characterised in that the sleeve 15 is substantially cylindrical and has a first annular bead 16 of a size allowing force-fitting past the inner edge of the upper ring 12 to ensure the retention of the latter, a second annular bead 18 of a size allowing force-fitting past the inner edge of the lower ring 13 and ensuring the retention of the latter, and a third annular bead 20 of a size allowing force-fitting past the inner edge of a lower annular member 11 and ensuring the retention of the latter with play, the lower annular member 11 forming part of a shock-absorber assembly for a vehicle with which the suspension thrust bearing 9 is to be utilised. The sleeve 15 has a dip 22 for engagement with the surface of the member 11 to act as a seal against ingress of water and dirt. The housing 25 has a similar lip 26 for engagement with upper ring 12. <IMAGE>